Dr.Reddy's-Corporate Web Ads 600x100 2_122021

	Alembic intros generic Saphris

	The medication is indicated for bipolar disorder and acute monotherapy of manic or mixed episodes in pediatric patients aged 10 to 17 years old.

FDA gives Lupin approval, tentative OK for 2 generics

The FDA gave Lupin approval for desvenlafaxine extended-release tablets and tentative approval for tenofovir alafenamide tablets.

Hikma acquires Custopharm

The acquisition complements Hikma’s product portfolio and pipeline, adding up to 13 approved products and additional pipeline products.

Breckenridge obtains FDA OK for generic Zavesca

Zavesca is used to treat adults with mild to moderate Type 1 Gaucher disease.

Nexus rolls out generic Erythrocin

Erythromycin lactobionate for injection is indicated in the treatment of infections caused by susceptible strains of designated organisms when oral administration is not possible.

Long Grove Pharmaceuticals to debut generic products

Long Grove Pharmaceuticals said it expects to innovate across the generic injectables, dermatological and topical markets.


	Most Popular


	Pure Leaf rolls out lower sugar iced teas


	Rite Aid confirms rejection of off-market proposal from Spear Point Capital Management


	Amazon unveils Buy with Prime


	AmerisourceBergen partners with Chronicled to enhance charge-back accuracy

Follow Us!

Don’t miss an email! Add us to your address book: info@mail.drugstorenews.com

View in Browser

8550 W. Bryn Mawr Ave. Ste. 200 Chicago, IL 60631

contact@drugstorenews.com | 1-877-687-7321

Unsubscribe | Unsubscribe from All | Subscribe to Our Magazine

Privacy Policy | Terms & Conditions

Most Popular

Follow Us!